Efficacy and safety of vildagliptin compared to placebo in patients with type 2 diabetes and mild hyperglycemia.
Phase of Trial: Phase III
Latest Information Update: 18 Feb 2015
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Novartis
- 31 Aug 2018 Biomarkers information updated
- 04 May 2012 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
- 05 Aug 2011 New source identifed and integrated (European Clinical Trials Database).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History